These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 614548)

  • 41. [Captopril in the treatment of mild cardiac insufficiency in combination with arterial hypertension].
    Ol'binskaia LI; Morozova TE
    Ter Arkh; 1987; 59(4):103-6. PubMed ID: 3296282
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Treatment of arterial hypertension using beta-blockaders].
    Cottier P
    Ther Umsch; 1974 Nov; 31(11):772-8. PubMed ID: 4154519
    [No Abstract]   [Full Text] [Related]  

  • 43. A comparison of the effects of the slow release formulations of metoprolol and oxprenolol in hypertension.
    Comerford MB; Besterman EM
    Ann Clin Res; 1982 Feb; 14(1):27-31. PubMed ID: 7137874
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Essential hypertension: current therapeutic approach].
    Manzi M; Santarossa C; Feriozzi S
    Clin Ter; 1982 Feb; 100(4):337-57. PubMed ID: 6177467
    [No Abstract]   [Full Text] [Related]  

  • 45. [New drug (Sensit) for the treatment of coronary disease in a double blind test].
    Pillen D
    Fortschr Med; 1974 Jun; 92(16):709-11. PubMed ID: 4600940
    [No Abstract]   [Full Text] [Related]  

  • 46. "24-hour blood pressure control" with sustained release oxprenolol 160mg plus cyclopenthiazide 0.25mg (Trasidrex) in general practice.
    Forrest WA; Bridgman KM; Ebbutt AF
    Br J Clin Pract; 1983; 37(11-12):385-8. PubMed ID: 6367794
    [No Abstract]   [Full Text] [Related]  

  • 47. [Studies on the antihypertensive effect of propranolol and oxprenolol in man].
    Gilfrich HJ; Nicolescu RF; Rahn KH; Willems D
    Verh Dtsch Ges Inn Med; 1971; 77():934-7. PubMed ID: 5156090
    [No Abstract]   [Full Text] [Related]  

  • 48. [Evaluation of a delayed-action beta blocker by 24-hour ambulatory recording of the arterial pressure].
    Campanini C; Adamec R; Barthélémy JC; Mérier G
    Schweiz Med Wochenschr; 1984 Jan; 114(1):19-24. PubMed ID: 6695162
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [New trends in the treatment of moderate arterial hypertension].
    Tomov I
    Vutr Boles; 1986; 25(1):7-16. PubMed ID: 2872752
    [No Abstract]   [Full Text] [Related]  

  • 50. [Multicenter study with a fixed combination of oxprenolol/chlorthalidone in essential arterial hypertension].
    Albanesi Filho FM; Benchimol AB
    Arq Bras Cardiol; 1980 May; 34(5):409-14. PubMed ID: 7006573
    [No Abstract]   [Full Text] [Related]  

  • 51. Antihypertensive activity of a fixed combination of oxprenolol and chlorthalidone in mild to moderate arterial hypertension.
    Motolese M; Agabiti-Rosei E; Carotti A; Innocenti P; Montervino C; Solinas E; Toso M; Muiesan G
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(8):332-7. PubMed ID: 7409934
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Combined alpha and beta adrenergic blockade in treatment of hypertension.
    Majid PA; Sharma B; Meeran MK; Taylor SH
    Br Heart J; 1973 May; 35(5):561. PubMed ID: 4716050
    [No Abstract]   [Full Text] [Related]  

  • 53. Oxprenolol in clinical practice.
    Taylor SH
    Am J Cardiol; 1983 Nov; 52(9):34D-42D. PubMed ID: 6356864
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oxprenolol: long-term effects in arterial hypertension.
    Gysling E; Regoli D
    Clin Pharmacol Ther; 1973; 14(6):995-1000. PubMed ID: 4584158
    [No Abstract]   [Full Text] [Related]  

  • 55. The acute and chronic effects of oxprenolol on ambulatory blood pressure and heart rate in essential hypertension [proceedings].
    Millar-Craig MW; Mann S; Balasubramanian V; Altman D; Raftery EB
    Br J Clin Pharmacol; 1979 Oct; 8(4):389P. PubMed ID: 508527
    [No Abstract]   [Full Text] [Related]  

  • 56. Sodium repletion and beta-adrenergic blockade in treatment of salt depletion with accelerated hypertension.
    Thomas RD; Lee MR
    Br Med J; 1976 Dec; 2(6049):1425-6. PubMed ID: 1009361
    [No Abstract]   [Full Text] [Related]  

  • 57. Initiation and maintenance of beta-blockade with intravenous oxprenolol.
    Silke B; John VA; Calvert RT; Taylor SH
    Eur J Clin Pharmacol; 1983; 24(1):7-14. PubMed ID: 6832204
    [No Abstract]   [Full Text] [Related]  

  • 58. Oxprenolol in the treatment of anxiety due to environmental stress.
    McMillin WP
    Am J Psychiatry; 1975 Sep; 132(9):965-6. PubMed ID: 1155635
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The effect of oxprenolol on operative stress in surgeons].
    Timio M; Gentili S; Lolli S; Martini F
    Boll Soc Ital Cardiol; 1979; 24(10):1091-4. PubMed ID: 400393
    [No Abstract]   [Full Text] [Related]  

  • 60. Oxprenolol plus cyclopenthiazide-kci versus methyldopa in the treatment of hypertension.
    Levenstein JH
    S Afr Med J; 1979 Apr; 55(17):656. PubMed ID: 462285
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.